Antifibrillatory actions of nadolol.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000818:Animals; D000889:Anti-Arrhythmia Agents; D003645:Death, Sudden; D004285:Dogs; D004558:Electric Stimulation; D008297:Male; D009203:Myocardial Infarction / Q000473:pathology / Q000503:physiopathology; D009248:Nadolol; D011412:Propanolamines / Q000494:pharmacology*; D013610:Tachycardia / Q000503:physiopathology; D014693:Ventricular Fibrillation / Q000503:physiopathology*
D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D011412:Propanolamines; D009248:Nadolol